[The impact of genetic engineering in hemorrhagic and thrombotic diseases].
D001778:Blood Coagulation Disorders / Q000628:therapy*; D005164:Factor IX; D005169:Factor VIII; D005818:Genetic Engineering; D006629:Hirudins; D006801:Humans; D013927:Thrombosis / Q000628:therapy*; D010959:Tissue Plasminogen Activator; D000515:alpha 1-Antitrypsin
D006629:Hirudins; D000515:alpha 1-Antitrypsin; D005169:Factor VIII; D005164:Factor IX; D010959:Tissue Plasminogen Activator
Impact du génie génétique dans les maladies hémorragiques et thrombotiques.